Clinical Trial Update: Antineoplaston Therapy in Treating Patients With Neurofibroma and Schwannoma [Phase 2]

View source ↗

Summary

A Phase 2 trial of Antineoplaston Therapy for neurofibroma and schwannoma sponsored by Burzynski Research Institute has been terminated.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Neurofibromatosis Type
• Neurofibromatosis Type 2
• Schwannoma

Drugs mentioned

• Antineoplaston Therapy (ANP) (antineoplaston)

Snippet

Sponsor: Burzynski Research Institute | Conditions: CNS Tumor | Phase 2 | Status: TERMINATED